Twenty-six years ago, Edvard Kalvesten started a PhD project at KTH Royal Institute of Technology. It was a modest affair. A researcher, a clean room, and some ideas about micro-electromechanical systems that most investors wouldn't touch. Today, the company that grew out of that lab, Silex Microsystems, just locked its IPO price at SEK 81 per share, valuing the business at SEK 8.9 billion (roughly $850 million). First day of trading on Nasdaq Stockholm: May 7.

That's not a typical Nordic startup exit story. There's no pivot narrative, no near-death fundraise, no celebrity VC riding in with a term sheet. Silex built a deep-tech business in Jarfalla, a suburb northwest of Stockholm that most Swedes couldn't place on a map, and quietly became the world's leading pure-play MEMS foundry.

The IPO prospectus, published this morning, reveals a company printing money. Revenue hit SEK 1.385 billion in 2025 with a 27% EBIT margin. First quarter 2026 was even better: SEK 375 million in sales and a 34% margin. For a hardware company serving defense, automotive, and medtech clients, those are software-like numbers.

MEMS, micro-electromechanical systems, sit inside the things you don't think about. Accelerometers in your phone. Pressure sensors in your car. Microphones in your earbuds. The market for these tiny devices is enormous and growing, driven by autonomous vehicles, 5G infrastructure, and medical diagnostics.

Silex doesn't design MEMS chips. It manufactures them for other companies, the same way TSMC fabricates processors for Apple and Nvidia. That pure-play foundry model, rare in MEMS, is what makes Silex unusual. Its customer list reads like a who's who of global tech. The company has averaged 17% annual revenue growth since 2015 without needing to raise venture capital along the way.

The Jarfalla facility runs 24/7. Silex plans to use IPO proceeds to expand clean-room capacity there by roughly 35%, and to build production capability in the United States. That US expansion isn't optional anymore. With geopolitical tensions reshaping semiconductor supply chains, having a fab on American soil is becoming a competitive requirement.

Here's the part that makes this IPO geopolitically interesting. Silex's majority owner is Sai MicroElectronics (SMEI), a Chinese semiconductor company that currently holds 45.2% of the shares through its subsidiary Global Access Electronics. After the IPO, SMEI's stake drops to 9.9%.

Meanwhile, Swedish investment firm Bure Equity will acquire shares from SMEI representing 19.1% of outstanding stock. The net effect: a strategic Swedish semiconductor asset shifts from Chinese to Swedish-European institutional ownership. Given the current climate around chip sovereignty, the timing feels deliberate.

The cornerstone investor list tells you something about who takes this seriously. Creades, the investment company run by Sven Hagstromer (who also chairs Avanza), is in. So are Sweden's Second, Third, and Fourth AP pension funds. Fidelity International, Swedbank Robur, Capital Research Global Investors, and Carnegie Fonder round out the group. Together they've committed to buying up to SEK 1.501 billion in shares.

That's not quiet interest. That's a queue of institutional money essentially saying: we'll take it before the market gets a chance to price it.

Hagstromer himself reportedly bought SEK 35 million worth of Creades stock this same morning, a signal within a signal for anyone paying attention.

The semiconductor conversation usually centers on logic chips, the processors and GPUs that power AI workloads. MEMS gets less attention. But these devices are the nervous system of the physical world. Every autonomous vehicle needs dozens of them. Every industrial robot. Every medical implant.

And unlike logic chip fabrication, where TSMC, Samsung, and Intel dominate, the MEMS foundry market is fragmented. Silex's claim to be the world's leading pure-play MEMS foundry isn't marketing fluff. The company serves customers across defense, automotive, consumer electronics, and medtech from a single highly specialized facility. That focus creates switching costs. Once a customer qualifies a MEMS process on Silex's line, moving to another foundry means months of re-qualification and testing.

Part of the IPO proceeds, combined with debt financing, will fund what Silex describes as approximately SEK 1.4 billion in investment across US production capacity, Jarfalla expansion, and potential acquisitions. The company hasn't specified where in the US it plans to build, but the CHIPS Act incentives make several states attractive.

A US production footprint would make Silex eligible for defense contracts that currently require domestic manufacturing. It would also hedge against the geopolitical risks that come with having all production in a single European site, regardless of how stable Sweden might seem.

For a company that started as a university research project, listing on a major exchange and building transatlantic manufacturing capacity is a remarkable trajectory. Most deep-tech hardware startups don't survive their first decade. Silex just printed a 34% EBIT margin in its 26th year. The IPO is the beginning of the next chapter, not the end of the story.